Ledger.Open graph →
SEC Form D · Amendment · filed August 27, 2014

Apellis Pharmaceuticals, Inc

Offering
$24.0M
Sold
$17.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CRESTWOOD, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Stephanie O'Brien · Monaco, O9DirectorAlec Machiels · New York, NYDirectorGerald Chan · Monaco, O9DirectorRobert M. Woomer · ATLANTA, GAExecGregory M. Friedman · ATLANTA, GAExec · DirectorMathew M. Crosswy · ATLANTA, GAExec · DirectorSs Hotel Credit Opportunity Fund, LLC · ATLANTA, GAExecMary F. Hinz · Santa Cruz, CADirectorTimothy Maudlin · Conshohocken, PADirectorRobert Dyke · Royal Oak, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗